Graeme Greenfield

7PUBLICATIONS
2CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2021
Molecular pathogenesis of the myeloproliferative neoplasms.

Graeme Greenfield, Mary Frances McMullin, Ken Mills

|Nov 04, 2020
Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort.

Olga Michail, Patrick McCallion, Julie McGimpsey

|Sep 23, 2020
Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms.

Graeme Greenfield, Suzanne McPherson, James Smith

|May 11, 2019
Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia.

Graeme Greenfield, Ross McMullan, Nuala Robson

|Dec 27, 2018
Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.

Graeme Greenfield, Olga Michail, Bridgin Merron

|Dec 22, 2018
Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms - long term follow-up of a regional case series.

Graeme Greenfield, Mary Frances McMullin

Pageof 2

Frequent Collaborators

3 joint publications

Mary Frances McMullin

2 joint publications

Mark Catherwood